Response After Phase 2 | Total | Chapter 1. Glycemic management (n = 124) | Chapter 2. Dyslipidemia (n = 111) | Chapter 3. Blood pressure control (n = 135) | Chapter 4. Anti-platelet therapy (n = 11) |
---|---|---|---|---|---|
PP cases marked “no” in Phase 1 | 259 | 92 | 70 | 92 | 5 |
“No” to “yes” | 228 | 79 | 66 | 82 | 1 |
“No” to “not sure” | 4 | 0 | 1 | 2 | 1 |
Unchanged “no” | 26 | 12 | 3 | 8 | 3 |
Missing | 1 | 1 | 0 | 0 | 0 |
PP cases marked “not sure” in Phase 1 | 135 | 39 | 33 | 46 | 17 |
“Not sure” to “yes” | 110 | 33 | 31 | 41 | 5 |
“Not sure” to “no” | 16 | 3 | 2 | 1 | 10 |
Unchanged “not sure” | 6 | 0 | 0 | 4 | 2 |
Missing | 3 | 3 | 0 | 0 | 0 |